Company / Operating Margin
Sarepta Therapeutics Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-31.8%
FY2025
5-year range
-104.5% / 11.5%
FY2021-FY2025
Trend
-377.5%
vs FY2024
Sector context
#73 of 136
Health Care
What the data says
Operating Margin changed -378% YoY in FY2025, a notable deviation from the 9-year average annual change of -7%.
Based on SEC 10-K filings.
-31.8% in FY2025 with a 5-year CAGR of +82.3%.
Declined from -21.5% to -31.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +72.6pp
- 5-Year Change
- +82.3pp
- 10-Year Change
- -
Sector benchmark
#73 of 136 in Health CareTop 54% of 136This company -31.8% Sector average -778.9%
▼
+95.9% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 377.5% year-over-year.
- Currently 747.1pp above the Health Care sector average.
- Peak operating margin was recorded in FY2024.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -31.8% | -377.5% |
| FY2024 | 11.5% | +153.2% |
| FY2023 | -21.5% | +79.4% |
| FY2022 | -104.5% | -59.5% |
| FY2021 | -65.5% | +42.6% |
| FY2020 | -114.1% | -2.8% |
| FY2019 | -111.0% | +2.7% |
| FY2018 | -114.1% | -2.8% |
| FY2017 | -111.0% | +97.7% |
| FY2016 | -4920.3% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026